NCT00304356View on ClinicalTrials.gov

Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Clostridium EnterocolitisPseudomembranous Colitis
Interventions
DRUG

Nitazoxanide

500 mg bid

Trial Locations (2)

77030

Baylor College of Medicine, Houston

Michael E. Debakey VA Medical Center, Houston

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

lead

Daniel M. Musher MD

FED

NCT00304356 - Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection | Biotech Hunter | Biotech Hunter